FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
58 | EARLY COCAINE-INDUCED PERIORIFICIAL DERMATOMUCOSITIS: A CASE SERIES EXPANDING THE CLINICOPATHOLOGICAL SPECTRUM BEYOND MIDLINE DESTRUCTIVE LESIONS V. Lora1, M. Di Prete2, C. Cota2 | 1Clinical Dermatology, San Gallicano Dermatological Institute IRCCS, Rome, Italy; 2Dermatopathology Research Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy
149PDF: 38 -
-
-
02 | Melanoma training in primary care: comparing traditional teaching with telemedicine-enhanced education. A review Giorgia Ravaglia1, Edoardo Mora2, Debora Cantagalli3, Serena Magi4, Laura Mazzoni4, Matelda Medri4, Cesare Massone5, Davide Melandri6, Federica Zamagni7, Ines Zanna8, Gianluca Pistore9, Saverio Caini8, Salvatore Amato10, Vincenzo De Giorgi11, Pietro Quaglino12, Maria Antonietta Pizzichetta13|14, Giovanni Luigi Tripepi15, Sofia Spagnolini1, Ignazio Stanganelli1|4 | 1Dermatology Resident Training Program, Department of Medicine and Surgery, University of Parma, Parma; 2Dermatology Unit, Ospedale S. Anna, Como; 3Primary Care Resident Training program, Ausl Bologna, Bologna; 4Skin Cancer Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" – IRST Meldola, Forlì-Cesena; 5Dermatology Unit, Ospedali Galliera, Genova; 6Dermatology Unit, AUSL Romagna and University of Bologna, Cesena. 7Registro Tumori della Regione Emilia Romagna, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST Meldola, Forlì-Cesena; 8Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, ISPRO, Florence; 9Clinical Epidemiology Unit, Istituto Dermopatico dell’Immacolata - IRCCS, Rome; 10Associazione Dermatologi Ospedalieri Italiani, ADOI, Sicilia and Teledermatology working group, Palermo; 11Dermatology, Department of Health Sciences, University of Florence, Florence; 12Dermatologic Clinic, Department of Medical Sciences, University of Turin, Torino; 13Department of Dermatology, University of Trieste, Trieste; 14Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, CRO, IRCCS, Aviano; 15CNR-IFC, Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
504 -
Certolizumab to treat hidradenitis suppurativa
1993PDF: 760HTML: 55 -
67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; 5Chang Gung University College of Medicine, Taoyuan, Taiwan; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; 8Department of Dermatology and Population Health Sciences, King’s College London, UK; 9Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; 11Eli Lilly and Company, Indianapolis, Indiana, USA; 12Almirall R&D, S.A., Barcelona, Spain; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
133PDF: 68 -
New therapeutic applications of ozenoxacin in superficial skin infections
2884PDF: 930Supplementary Files: 458HTML: 25 -
-
Side-effects to the use of laptop computers: erythema ab igne
3791PDF: 764HTML: 1690 -
Psoriasis treatments in Europe during the 19th century
604PDF: 379HTML: 36 -
08 | Cutaneous melanoma and occupational UV exposure: associations with anatomical site, histological subtype, and Breslow thickness Federica Fazzari, Giovanni Cecchi, Gabriella Perill, Biancamaria Zuccaro, Vincenzo De Giorgi | Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
473 -
-
56 | FIRST-LINE EXTRACORPOREAL PHOTOPHERESIS PLUS INTERFERON-Α IN SÉZARY SYNDROME: REAL-WORLD SURVIVAL AND EXPLORATORY BLOOD BIOMARKERS A. Di Guardo1, M.P. Accetturi1, C. Cristofoletti1, A. Frezzolini1, E. Scala1, L. Fania1|2, A. Monopoli1, M.G. Narducci1 | 1IDI-IRCCS, Dermatological Research Hospital, Italy; 2Department of Life Science, Health, and Health Professions, Link University of Rome, Italy
104PDF: 114 -
28 | Efficacy and toxicity outcomes with doublet immunotherapy in metastatic melanoma: the real-world REALIPINIVO study Miriam Forte1, Francesco Caraglia1, Silvana Cozzolino1, Antonino Colloca1, Alfonso Esposito1, Maria Cristina Giugliano1, Eleonora Cioli1, Marcella Scala2, Francesca Sparano5, Maria Chiara Sergi3, Teresa Del Giudice4, Immacolata Paciolla6, Luigi Formisano2, Stefania Napolitano1, Antonio Maria Grimaldi6, Paolo Antonio Ascierto5, Fortunato Ciardiello1, Teresa Troiani1, Vincenzo De Falco1 | 1Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples; 2Department of Clinical Medicine and Surgery, Federico Il University, Naples; 3Unità Operativa Complessa di Oncologia Medica, Ospedale "Mons. A.R. Dimiccoli", Barletta; 4Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; 5Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Napoli; 6Medical Oncology Unit AORN "San Pio", Benevento, Italy.
450
